Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting

by Philippe De Deurwaerdère, Abdeslam Chagraoui, Abdeslam Chagraoui, Kathryn A. Cunningham
Published 2020-11-01

Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases

by Philippe De Deurwaerdère, Abdeslam Chagraoui
Published 2021-05-01

Editorial: New GPCR targets and modulators to treat CNS disorders

by Philippe De Deurwaerdère, Evgeni Ponimaskin, Abdeslam Chagraoui, Abdeslam Chagraoui, Giuseppe Di Giovanni, Giuseppe Di Giovanni
Published 2022-12-01

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats

by Philippe De Deurwaerdère, Maurizio Casarrubea, Daniel Cassar, Manuela Radic, Emilie Puginier, Abdeslam Chagraoui, Abdeslam Chagraoui, Abdeslam Chagraoui, Giuseppe Crescimanno, Vincenzo Crunelli, Giuseppe Di Giovanni, Giuseppe Di Giovanni
Published 2022-05-01

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease

by Abdeslam Chagraoui, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Published 2022-02-01

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain

by Giuseppe Di Giovanni, Giuseppe Di Giovanni, Rahul Bharatiya, Rahul Bharatiya, Emilie Puginier, Marta Ramos, Salomé De Deurwaerdère, Abdeslam Chagraoui, Abdeslam Chagraoui, Philippe De Deurwaerdère
Published 2020-06-01

Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA

by Giuseppe Di Giovanni, Abdeslam Chagraoui, Emilie Puginier, Salvatore Galati, Philippe De Deurwaerdère
Published 2019-08-01

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning

by Abdeslam Chagraoui, Marie Boulain, Laurent Juvin, Youssef Anouar, Grégory Barrière, Philippe De Deurwaerdère
Published 2019-12-01

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT_2C Receptors in Rats: Implication of the Subthalamic Nucleus

by Mélanie Lagière, Marion Bosc, Sara Whitestone, Abdelhamid Benazzouz, Abdeslam Chagraoui, Mark J. Millan, Philippe De Deurwaerdère
Published 2020-11-01

Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?

by Bojan Mirkovic, Bojan Mirkovic, Abdeslam Chagraoui, Priscille Gerardin, Priscille Gerardin, David Cohen, David Cohen, David Cohen
Published 2020-06-01

Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats

by Inès Khsime, Marie Boulain, Abderrahman Fettah, Abdeslam Chagraoui, Gilles Courtand, Philippe De Deurwaerdère, Laurent Juvin, Grégory Barrière
Published 2023-09-01

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain

by Rahul Bharatiya, Abdeslam Chagraoui, Salomé De Deurwaerdere, Antonio Argiolas, Maria Rosaria Melis, Fabrizio Sanna, Philippe De Deurwaerdere
Published 2020-08-01

Effect of the 5-HT_2C Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study

by Sara Whitestone, Philippe De Deurwaerdère, Lynn Baassiri, Julien Manem, Youssef Anouar, Giuseppe Di Giovanni, Rahul Bharatiya, Abdeslam Chagraoui
Published 2019-06-01

Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models

by Ifat Alsharif, Loubna Boukhzar, Benjamin Lefranc, David Godefroy, Juliette Aury-Landas, Jean-Luc do Rego, Jean-Claude do Rego, Frédéric Naudet, Arnaud Arabo, Abdeslam Chagraoui, David Maltête, Abdelhamid Benazzouz, Catherine Baugé, Jérôme Leprince, Abdel G. Elkahloun, Lee E. Eiden, Youssef Anouar
Published 2021-04-01